[{"address1": "41 \u2013 47 Colin Street", "address2": "Suite 3", "city": "West Perth", "state": "WA", "zip": "6005", "country": "Australia", "phone": "61 8 6555 2945", "fax": "61 8 6210 1153", "website": "https://www.botanixpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia and the United States. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIa clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase II clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. Botanix Pharmaceuticals Limited was incorporated in 1984 and is based in West Perth, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Vincent P. Ippolito", "age": 65, "title": "MD & Executive Chairman", "yearBorn": 1959, "fiscalYear": 2025, "totalPay": 715546, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Howie  McKibbon", "title": "Chief Executive Officer", "fiscalYear": 2025, "totalPay": 639390, "exercisedValue": 1849948, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Graeme  Morissey", "title": "Chief Financial Officer", "fiscalYear": 2025, "totalPay": 83324, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chris  Lesovitz", "title": "Chief Financial Officer of United States of America", "fiscalYear": 2025, "totalPay": 427412, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patricia S. Walker M.D., Ph.D.", "age": 65, "title": "Chief Medical Adviser & Non-Executive Director", "yearBorn": 1959, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Boris  Meyerson Ph.D.", "title": "Chief Business Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Morgan", "title": "Head of Corporate Affairs", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Wojciechowski", "title": "Head of HCP Marketing & Sales Training", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Darin  Van Arsdale", "title": "Director of Sales Operations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 1, "overallRisk": 9, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.08, "open": 0.08, "dayLow": 0.08, "dayHigh": 0.08, "regularMarketPreviousClose": 0.08, "regularMarketOpen": 0.08, "regularMarketDayLow": 0.08, "regularMarketDayHigh": 0.08, "payoutRatio": 0.0, "beta": 0.918, "volume": 20000, "regularMarketVolume": 20000, "averageVolume": 12155, "averageVolume10days": 24000, "averageDailyVolume10Day": 24000, "bid": 0.075, "ask": 0.099, "bidSize": 30000, "askSize": 5000, "marketCap": 163425600, "fiftyTwoWeekLow": 0.0619, "fiftyTwoWeekHigh": 0.34, "priceToSalesTrailing12Months": 28.22944, "fiftyDayAverage": 0.127378, "twoHundredDayAverage": 0.226911, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 93141312, "profitMargins": 0.0, "floatShares": 1717633159, "sharesOutstanding": 1961330048, "heldPercentInsiders": 0.122889996, "heldPercentInstitutions": 0.22769, "impliedSharesOutstanding": 2042819968, "bookValue": 0.041, "priceToBook": 1.9512194, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -86396184, "trailingEps": -0.03, "enterpriseToRevenue": 16.089, "enterpriseToEbitda": -1.155, "52WeekChange": -0.704797, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 0.08, "recommendationKey": "none", "totalCash": 64966580, "totalCashPerShare": 0.033, "ebitda": -80650936, "totalDebt": 1217759, "quickRatio": 2.735, "currentRatio": 3.996, "totalRevenue": 5789190, "debtToEquity": 1.498, "revenuePerShare": 0.003, "returnOnAssets": -0.42905998, "returnOnEquity": -0.90928, "grossProfits": 2017687, "freeCashflow": -38580200, "operatingCashflow": -78584744, "revenueGrowth": 2.199, "grossMargins": 0.34853, "ebitdaMargins": 0.0, "operatingMargins": -9.41374, "financialCurrency": "AUD", "symbol": "BXPHF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "corporateActions": [], "regularMarketTime": 1757635200, "exchange": "PNK", "messageBoardId": "finmb_324672225", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.08, "longName": "Botanix Pharmaceuticals Limited", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 12155, "fiftyTwoWeekLowChange": 0.018099997, "fiftyTwoWeekLowChangePercent": 0.29240707, "fiftyTwoWeekRange": "0.0619 - 0.34", "fiftyTwoWeekHighChange": -0.26, "fiftyTwoWeekHighChangePercent": -0.76470584, "fiftyTwoWeekChangePercent": -70.479706, "earningsTimestampStart": 1753786740, "earningsTimestampEnd": 1754308800, "earningsCallTimestampStart": 1726533000, "earningsCallTimestampEnd": 1726533000, "isEarningsDateEstimate": true, "shortName": "Botanix Pharmaceuticals Ltd.", "marketState": "CLOSED", "epsTrailingTwelveMonths": -0.03, "fiftyDayAverageChange": -0.047378004, "fiftyDayAverageChangePercent": -0.3719481, "twoHundredDayAverageChange": -0.146911, "twoHundredDayAverageChangePercent": -0.6474389, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1568035800000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.08 - 0.08", "displayName": "Botanix Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]